Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Corcept Therapeutics Inc
Swot
Corcept Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Corcept Therapeutics Inc has 13 Strengths, 9 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(13)
Weakness
(9)
Opportunity
(4)
Threats
(0)
Others
(1)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Consistent Highest Return Stocks over Five Years - Nifty500
Relative Outperformance versus Industry over the Quarter (3 Months)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Company with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
Promoter decreasing their shareholding
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Top Losers
Declining Net Cash Flow : Companies not able to generate net cash
Weak performer : Stock lost more than 20% in 1 month
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Top Losers
Mutual Funds Increased Shareholding in Past Month
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
